In a turbulent period for biotech firms, Evaxion Biotech AS (EVAX) has seen its stock price plummet to $2.38, though InvestingPro analysis suggests the stock may be undervalued. According to ...
After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...
Biotech Showcaseâ„¢ 2025 Opens the Year with More than 3,000 Attendees, 340+ Presenting Companies, 1,020+ Investors and 85+ Members of the Media ...
Working with the Langer and Jaklenec Labs, this collaboration will develop ‘solutions to combat the effects of visible light from the sun.’ ...
While the Chicago metropolitan area is not a major life sciences hub, a recent Cushman & Wakefield report predicts the Chicago market should be a growth spot in the coming years. Chicago Biomedical ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, today we look at ...
From working at major sports stadiums to wedding venues + science labs, these agricultural jobs might surprise you 👇 NowPartner #auburnagriculture #alabamajobs ...
Evaxion Biotech (EVAX) shares fell over 25% premarket on Thursday after the company priced an offering to raise $10.8M. The ...
The layoffs will allow Ironwood to dedicate more resources to pushing its lead molecule apraglutide through a Phase III trial ...
Sanofi has removed a clutch of programs from its clinical pipeline, scratching out entries for its late-phase BTK inhibitor and phase 1 prospects linked to the multibillion-dollar takeovers of Ablynx, ...
The glut of life science office and lab space in San Diego County rose to an all-time high in 2024 and it’s expected to ...
WALTHAM, Mass. and BOULDER, Colo., Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: COGT), a biotechnology company focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback